ArticleThe oncologist2023

Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors.

Igor Stukalin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.